Enhancing the efficacy of fluocinolone acetonide by encapsulating with PLGA nanoparticles and conjugating with linear PEG polymer

References

• Pharmaceutical manufacturing encyclopedia. 3rd ed. Vol. 1. Norwich (NY). William Andrew Publishing; 2006. p.1656.
   Google Scholar
• Ayalasomayajula SP, Ashton P, Kompella UB. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-α-induced angiogenesis in chick chorioallantoic membrane (CAM). J Ocul Pharmacol Ther. 2009;25:97–104.
   PubMed Web of Science ®Google Scholar
• Sarao V, Veritti D, Boscia F, et al. Intravitreal steroids for the treatment of retinal diseases. Sci World J. 2014;2014:1.
   Google Scholar
• Kuno N, Fujii S. Recent advances in ocular drug delivery systems. Polymers. 2011;3:193–221.
   Web of Science ®Google Scholar
• Bourges JL, Gautier SE, Delie F, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci. 2003;44:3562–3569.
   PubMed Web of Science ®Google Scholar
• Iezzi R, Guru BR, Glybina IV, et al. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials 2012;33:979–988.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Dekker M. Colloidal drug delivery systems. Clin Res Regulat Affairs. 1994;12:219–342.
   Google Scholar
• Read SP, Cashman SM, Kumar-Singh R. A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo. J Gene Med. 2010;12:86–96.
   PubMed Web of Science ®Google Scholar
• Li VH, Wood RW, Kreuter J, et al. Ocular drug delivery of progesterone using nanoparticles. J Microencapsul. 1986;3:213–218.
   PubMedGoogle Scholar
• Einmahl S, Savoldelli M, D'Hermies F, et al. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci. 2002;43:1533–1539.
   PubMed Web of Science ®Google Scholar
• Yandrapu KS, Upadhyay AK, Petrash JM, et al. Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharmaceutics. 2013;10:4676–4686.
   PubMed Web of Science ®Google Scholar
• Pan Q, Xu Q, Boylan NJ, et al. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. J Control Release. 2015;201:32–40.
   PubMed Web of Science ®Google Scholar
• Arcinue CA, Cerón OM, Foster CS. A comparison between the fluocinolone acetonide (retisert) and dexamethasone (ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther. 2013;29:501–507.
   PubMed Web of Science ®Google Scholar
• Kane FE, Burdan J, Cutino A, et al. Iluvien: A New Sustained Delivery Technology For Posterior Eye Disease. Expert Opin Drug Deliv. 2008;5:1039–1046.
   PubMed Web of Science ®Google Scholar
• Abuchowski A, van Es T, Palczuk NC, et al. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 1977;252:3578–3581.
   PubMed Web of Science ®Google Scholar
• Pasut G, Guiotto A, Veronese F. Protein, peptide and non-peptide drug pegylation for therapeutic application. Expert Opin Ther Pat. 2004;14:859–894.
   Web of Science ®Google Scholar
• Greenwald RB, Choe YH, Mcguire J, et al. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev. 2003;55:217–250.
   PubMed Web of Science ®Google Scholar
• Turecek PL, Bossard MJ, Schoetens F, et al. PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs. J Pharmaceut Sci. 2016;105:460–475.
   PubMed Web of Science ®Google Scholar
• Hakkimane SS, Shenoy VP, Gaonkar SL, et al. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacteriumm tuberculosis H37Rv strain. Int J Nanomedicine. 2018;13:1–16.
   Google Scholar
• Ito T, Fraser IP, Yeo Y, et al. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 2007;28:1778–1786.
   PubMed Web of Science ®Google Scholar
• Wen ZS, Liu LJ, Qu YL, et al. Chitosan nanoparticles attenuate hydrogen peroxide-induced stress injury in mouse macrophage RAW2647 cells. Marine Drugs. 2013;11:3582–3600.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011;3:1–19.
   Web of Science ®Google Scholar
• Lewis DH. Biodegradable polymers as drug delivery systems. 45th ed. Chasin M, Langer R, editors. New York (NY): Marcel Dekker, Inc; 1990. 251 p.
   Google Scholar
• Reichle ML. Complications of intravitreal steroid injections. Optometry 2005;76:450–460.
   PubMedGoogle Scholar
• Akçay H, Anagün AS. Multi response optimization application on a manufacturing factory. MCA. 2013;1:531–538.
   Google Scholar
• Gu F, Zhang L, Teply BA, et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA. 2008;105:2586–2591.
   PubMed Web of Science ®Google Scholar
• Salopek B, Krasic D, Filipovic S. Measurement and application of zeta-potential. Rudarsko-Geolosko-Naftni Zbornik. 1992;4:147–151.
   Google Scholar
• Ding Z, Jiang Y, Liu X. Nanemulsions-based drug delivery for brain tumors. In: Nanotechnology-based targeted drug delivery systems for brain tumors. Cambridge (MA): Elsevier Inc. 2018; p. 327–58.
   Google Scholar
• Ahmad Z, Maqbool M, Raja A. F. Nanomedicine for tuberculosis: insight from animal models. Int J Nano Dim. 2011;2:C7–84.
   Google Scholar
• Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med. 2013;13:e23.
   Web of Science ®Google Scholar
• Petrova TV, Akama KT, Eldik LJ. Van Selective modulation of BV-2 microglial activation by prostaglandin E2. J Biol Chem. 1999;274:28823–28827.
   PubMed Web of Science ®Google Scholar